Updated 1-Sep-2014
Adventist HealthCare Limited Human Research Ethics Committee
RESEARCH PROJECTS
Please note: This document is updated at regular intervals and indicates a projects status at the time the update was issued. If you
require confirmation regarding the current status of a project please phone the HREC Executive Officer on (m) 0417 042 300.
Project
Code
2014-020
Title
Researcher
Approved Date
Status
The Vascutek Thoraflex™ Hybrid Post
Market Surveillance
Professor Tristan Yan
Consultant Cardiothoracic Surgeon
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
30-Jul-2014
Approved
2014-019
A Randomized Multicenter Pivotal
Study of CDX-011 (CR011-vcMMAE)
in Patients with Metastatic, GPNMB
Over-Expressing, Triple-Negative
Breast Cancer (The "METRIC" Study)
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
23-Jul-2014
Approved
2014-018
ANZUP1304 : A randomised phase 3
trial of enzalutamide in first line
androgen deprivation therapy for
metastatic prostate cancer
(ENZAMET)
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
21-Jul-2014
Approved
2014-017
PUMA-NER-1301: A study of Neratinib
plus Capecitabine versus Lapatinib
plus Capecitabine in patients with
HER2+ Metastatic Breast Cancer who
have received two or more prior
HER2-directed regimes in the
metastatic setting [NALA]
ANZUP 1302 : Phase 3 Accelerated
BEP Trial: A randomised phase 3 trial
of accelerated versus standard BEP
chemotherapy for participants with
intermediate and poor-risk metastatic
germ cell tumours (P3BEP Trial)
A multi-centre, single-arm, open-label,
post-marketing safety study to
evaluate the risk of seizure among
subjects with Metastatic CastrationResistant Prostate Cancer (MCRPC)
treated with enzalutamide who are at
potential increased risk of seizure
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
21-Jul-2014
Approved
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
21-Jul-2014
Approved
Associate Professor Henry Woo
Australian Clinical Trials Pty Ltd
Australian Clinical Trials
Suite 406 San Clinic
185 Fox Valley Road
Wahroonga NSW 2076
04-Aug-2014
Approved
PCI-32765FLR3001: A Randomised,
Double-blind, Placebo-controlled
Phase 3 Study of the Bruton's
Tyrosine Kinase Inhibitor, PCI-32765
(Ibrutinib), in Combination with Either
Bendamustine and Rituximab (BR) or
Rituximab, Cyclophosphamide,
Doxorubicin, Vincristine, and
Prednisone (R-CHOP) in Subjects with
Previously Treated Indolent NonHodgkin Lymphoma (iNHL)
Case Study: Ultrasound identification
of slipped lap band
Dr Jane Freeman
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
30-Jun-2014
Approved
Dr Justin Bowra
SAH ED
28 Cambridge St
Paddington NSW 2021
30-Jun-2014
Approved
2014-016
2014-015
2014-014
2014-013
Updated 1-Sep-2014
2014-012
The MILO Study (MEK Inhibitor in
Low-Grade Serous Ovarian Cancer): A
Multinational, Randomized, Open-label
Phase 3 Study of MEK162 vs.
Physician's Choice Chemotherapy in
Patients with Recurrent or Persistent
Low-grade Serous Carcinomas of the
Ovary, Fallopian Tube or Primary
Peritoneum
Does prior abiraterone or
enzalutamide attenuate the effect of
subsequent docetaxel chemotherapy
in castrate resistant prostate cancer
Dr Joseph Rutovitz
San Clinical Trials Unit
Adventist HealthCare Limited
185 Fox Valley Road
Wahroonga NSW 2076
16-Jun-2014
Approved
Dr Malinda Itchins
Oncology Registrar with Dr Marx
403 San Clinic
185 Fox Valley Road
Wahroonga NSW 2076
16-Jun-2014
Approved
2014-010
Testicular Cancer Data Set
Specification Pilot Project
Associate Professor Henry Woo
Australian Clinical Trials Pty Ltd
Australian Clinical Trials
Suite 406 San Clinic
185 Fox Valley Road
Wahroonga NSW 2076
02-Jun-2014
Approved
2014-009
Correlating Ki67 and other prognostic
markers with Oncotype DX recurrence
score in early breast cancer
Monitoring psychiatric side-effects in
patients receiving high dose
glucocorticoids for medical conditions:
A pilot study
Dr Kazi Nahar
Registrar to Dr Gavin Marx
30-Apr-2014
Approved
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
14-Apr-2014
Approved
Amgen Protocol (Denosumab)
20120249: A Randomized, Doubleblind, Multi-centre Phase 2 Trial of
Denosumab in Combination with
Chemotherapy as First-line Treatment
of Metastatic Non-small Cell Lung
Cancer
PREVAIL: A multinational Phase 3,
randomized, double-blind placebocontrolled efficacy and safety study of
oral MDV3100 in chemotherapy-naive
patients with progressive metastatic
prostate cancer who have failed
androgen deprivation therapy - Open
Label (MDV3100-03)
Efficacy and tolerability study of
Promega-7 lotion in skin conditioning
in aged skin (Macadamia Cream
Study)
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
14-Apr-2014
Approved
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
31-Mar-2014
Approved
Associate Professor Ross Grant
CEO - Australasian Research
Institute
Chief Scientist
Australasian Research Institute
185 Fox Valley Road
Wahroonga NSW 2076
26-May-2014
Approved
2014-004
The Influence Of Selected Lifestyle
Factors On Maternal And Neonatal
Health: In Particular Oxidative And
Inflammatory Related Markers
Associate Professor Ross Grant
CEO - Australasian Research
Institute
Chief Scientist
Australasian Research Institute
185 Fox Valley Road
Wahroonga NSW 2076
24-Feb-2014
Approved
2014-003
PROSPER: A Multinational, Phase 3,
Randomized, Double Blind, Placebo
Controlled, Efficacy and Safety Study
of Enzalutamide in Patients with Nonmetastatic Castration Resistant
Cancer (MDV3100-14)
Hypocalcaemia in patients with
metastatic bone disease receiving
Denosumab
BNITPRV301: A Randomized, Doubleblind, Phase 3 Efficacy Trial of
PROSTVACV/F ± GMCSF in Men
With Asymptomatic or Minimally
Symptomatic Metastatic, Castrate
Resistant Prostate Cancer
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
07-Feb-2014
Approved
Dr Kazi Nahar
Registrar to Dr Gavin Marx
03-Feb-2014
Approved
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
20-Jan-2014
Approved
2014-011
2014-008
2014-007
2014-006
2014-005
2014-002
2014-001
Updated 1-Sep-2014
2013-036
Development of prediction model to
identify heart failure patients with high
risk of developing hyponatremia during
hospitalisation
Mr Saepudin Saepudin
PhD in School of Biomedical
Sciences, Charles Sturt University
4/6 Lampe Avenue
Wagga Wagga NSW 2650
2013-035
A Phase 4, Randomized, DoubleBlind, Placebo-Controlled Study of
Continued Enzalutamide Treatment
Beyond Progression in Patients With
Chemotherapy-Naive Metastatic
Castration-Resistant Prostate Cancer
(MDV3100-10)
Prevalence of pre-consultation internet
search of specialists who patients
have been referred to
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
09-Dec-2013
Approved
Associate Professor Henry Woo
Australian Clinical Trials Pty Ltd
Australian Clinical Trials
Suite 406 San Clinic
185 Fox Valley Road
Wahroonga NSW 2076
09-Dec-2013
Approved
2013-033
Data collection on pain outcomes of
men undergoing a TRUS biopsy
Associate Professor Henry Woo
Australian Clinical Trials Pty Ltd
Australian Clinical Trials
Suite 406 San Clinic
185 Fox Valley Road
Wahroonga NSW 2076
02-Dec-2013
Approved
2013-032
A diagnostic study to determine the
prevalence of EGFR mutations in
Asian and Russian patients with
advanced NSCLC of Adenocarcinoma
and Non-adenocarcinoma histologies:
The IGNITE study
A Phase 4, Randomized, DoubleBlind, Placebo-Controlled Study of
Continued Enzalutamide Treatment
Beyond Progression in Patients With
Chemotherapy-Naive Metastatic
Castration-Resistant Prostate Cancer
(MDV3100-10)
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
02-Dec-2013
Approved
Associate Professor Henry Woo
Australian Clinical Trials Pty Ltd
Australian Clinical Trials
Suite 406 San Clinic
185 Fox Valley Road
Wahroonga NSW 2076
27-Nov-2013
Approved
2013-034
2013-031
2013-030
2013-029
2013-028
2013-027
2013-026
Ethics Committee endorsement as an
Authorised Prescriber of an
unapproved product under section
19(5) of the Therapeutic Goods Act
XL 184-308: A Phase 3 randomized,
controlled study of Cabozantinib (XL
184) vs. Everolimus in subjects with
metastatic renal cell carcinoma that
has progressed after prior VEGFR
Tyrosine Kinase Inhibitor Therapy
Retrospective audit of the outcomes
following oesophagectomy at Sydney
Adventist Hospital
Archived - Never
Approved
Archived - Withdrawn
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
28-Oct-2013
Approved
Dr Stephanie Phillips
Consultant Anaesthetist,
Sydney Adventist Hospital Clinical
School
406A San Clinic
185 Fox Valley Road
Wahroonga NSW 2076
28-Oct-2013
Approved
Comparison of kinemyography (KMG)
with electromyography (EMG) for
measurement of neuromuscular
blockade during anaesthesia in
humans
Dr Paul Stewart
AMO
Consultant Anaesthesia
28-Oct-2013
Study Complete
Survey of Practice of Induction of
Labour in NSW Wales Hospitals
Dr Tanya Nippita
Lecturer, Sydney Medical School Northern
The University of Sydney
Sydney Medical School - Northern
The University of Sydney
Building 52, Level 2
Royal North Shore Hospital
St Leonards NSW 2065
22-Oct-2013
Approved
PO Box 82
Wahroonga NSW 2076
Updated 1-Sep-2014
2013-025
A phase 3, randomised, double-blind,
controlled trial of Cabozantinib
(XL184) vs Mitoxantrone plus
Prednisone in men with previously
treated symptomatic castrationresistant prostate cancer (COMET-2)
MDV3100-14: PROSPER: A
Multinational, Phase 3, Randomised,
Double-Blind, Placebo-Controlled,
Efficacy and Safety Study of
Enzalutamide in Patients with
Nonmetastatic Castration-Resistant
Prostate Cancer
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
14-Oct-2013
Approved
Associate Professor Henry Woo
Australian Clinical Trials Pty Ltd
Australian Clinical Trials
Suite 406 San Clinic
185 Fox Valley Road
Wahroonga NSW 2076
09-Oct-2013
Approved
2013-023
Evaluation of the 5:2 intermittent
Energy Restriction (IER) diet
Associate Professor Ross Grant
CEO - Australasian Research
Institute
Chief Scientist
Australasian Research Institute
185 Fox Valley Road
Wahroonga NSW 2076
28-Oct-2013
Approved
2013-022
Correlation of modifiable lifestyle
factors to markers of oxidative stress
and inflammation; application to the
development of a clinically relevant
'wellness' diagnostic score
Associate Professor Ross Grant
CEO - Australasian Research
Institute
Chief Scientist
Australasian Research Institute
185 Fox Valley Road
Wahroonga NSW 2076
28-Oct-2013
Approved
2013-021
CO.23: A Phase III randomised study
of BB1608 and best supportive care
versus placebo and best supportive
care in patients with pretreated
advanced colorectal carcinoma
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
07-Aug-2013
Archived - Discontinued
2013-020
The evaluation of post-graduate
training and welfare of medical intern
workforce in the private health sector
Dr June Strong
Medical Services Coordinator
Medical Services Coordinator
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
30-Jul-2013
Approved
2013-019
A three-arm, randomized, open label,
phase II study of everolimus in
combination with exemestane versus
everolimus alone versus capecitabine
in the treatment of postmenopausal
women with estrogen receptor
positive, locally advanced, recurrent,
or metastatic breast cancer after
recurrence or progression on prior
letrozole or anastrozole [BOLERO]
Clinical outcomes: Upper Extremity
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
29-Jul-2013
Approved
Dr David Duckworth
116 Macquarie Street
Parramatta NSW 2150
18-Jun-2013
Approved
2013-017
How effective is transdermal
administration of Adenoysl cobalamin
and Methyl cobalamin (biologically
available analogues of vitamin B12) in
the treatment and prevention of
vitamin B12 deficiency?
Dr Bevan Hokin
Director of Pathology
Pathology Director
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
18-Dec-2013
Approved
2013-016
ACORN: "Arthroplasty Clinical
Outcomes Registry NSW" and
incorporated sub-study "Improving
services and outcomes for joint
replacements"
Nutritional intake of inpatients in an
acute care private hospital post-trial
implementation of an expanded midmeal menu service
Professor Ian Harris
18-Jun-2013
Approved
Ms Jodie Privett
APD
23-May-2013
Approved
2013-024
2013-018
2013-015
Updated 1-Sep-2014
2013-014
Prostate cancer data set specification
pilot project
Associate Professor Henry Woo
Australian Clinical Trials Pty Ltd
Australian Clinical Trials
Suite 406 San Clinic
185 Fox Valley Road
Wahroonga NSW 2076
20-May-2013
Archived - Study Complete
2013-013
Contaminated waste segregation
using the C64 clinical waste bin
system (Clinismart)
Ms Fiona DeSousa
Infection Prevention & Control
Coordinator
29-Apr-2013
Archived - Study Complete
24-Apr-2013
Approved
Infection Prevention & Control
Coordinator
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
2013-012
A Phase II, randomized study of
Paclitaxel with GDC-0941 versus
Paclitaxel with placebo in patients with
locally recurrent or metastatic breast
cancer (PEGGY)
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
2013-011
Impact of high-potency Omega-3
supplementation on Metabolic Disease
Associate Professor Ross Grant
CEO - Australasian Research
Institute
Chief Scientist
Australasian Research Institute
185 Fox Valley Road
Wahroonga NSW 2076
2013-010
Natural course of hot flash symptoms
in men receiving AndrogenDeprivation Therapy for Prostate
Cancer - A Pilot Investigation
Associate Professor Henry Woo
Australian Clinical Trials Pty Ltd
Australian Clinical Trials
Suite 406 San Clinic
185 Fox Valley Road
Wahroonga NSW 2076
29-Apr-2013
Approved
2013-009
Does the timing of intraoperative
NSAID improve pain outcomes
following ureteroscopy?
Dr Helen Nicholson
Urology Registrar SAH
Department of Urology
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
15-Mar-2013
Approved
2013-008
Master of Biostatistics research
project: Statistical modelling of
cholesterol and liver function tests by
age, gender and time
Associate Professor Gillian Heller
Statistics Department
Building E4A, Room 533
25-Feb-2013
Approved
25-Feb-2013
Approved
Archived - Never
Approved
Macquarie University NSW 2109
2013-007
PEGASUS - Prevalence and severity
of genito-urinary symptoms in women
receiving adjuvant endocrine therapy
for early stage breast cancer and their
association with sexual dysfunction
and impact on quality of life - A
prospective study
Dr Mariana Sousa
Ob/Gyn, PhD Candidate
Psychosocial Research Group
Prince of Wales Hospital
Dickinson Building, Level 3
2013-006
Initial interactions of Herpes Simplex
virus with innate immune cells in
human skin
Dr Ralph Cohen
SAN Clinic
Sydney Adventist Hospital
Fox Valley Road
Wahroonga NSW 2076
29-Jan-2013
Approved
2013-005
Developing an antimicrobial
stewardship model for Australian
private hospitals
Mr Menino Osbert Cotta
16-Jan-2013
Approved
RANDWICK NSW 2031
Updated 1-Sep-2014
2013-004
Correlation of biophotonic skin
carotenoid score with food frequency
questionnaire: effects of
biodemographic, biochemical and
physiological parameters
Associate Professor Ross Grant
CEO - Australasian Research
Institute
Chief Scientist
Australasian Research Institute
185 Fox Valley Road
Wahroonga NSW 2076
06-Feb-2013
Approved
2013-003
A randomized, double-blind,
comparative study of ZYTIGA
(Abiraterone Acetate) plus low-dose
Prednisone plus Androgen Deprivation
Therapy (ADT) versus ADT alone in
newly diagnosed subjects with highrisk, metastatic hormone-naive
prostate cancer (mHNPC)
(LATITUDE)
Intravenous lignocaine infusion for
analgesia following laparoscopic
hiatus hernia repair: A double-blinded,
randomised, placebo-controlled trial
Associate Professor Henry Woo
Australian Clinical Trials Pty Ltd
Australian Clinical Trials
Suite 406 San Clinic
185 Fox Valley Road
Wahroonga NSW 2076
06-Feb-2013
Approved
Dr Stephanie Phillips
Consultant Anaesthetist,
Sydney Adventist Hospital Clinical
School
406A San Clinic
185 Fox Valley Road
Wahroonga NSW 2076
27-Mar-2013
Archived - Discontinued
2013-001
Are private hospitals suitable training
sites for prevocational trainees? A
study of patient satisfaction
Ms Marilyn Algeo
MO and Resident Services Manager
| Medical Services
Medical Services
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
17-Dec-2012
Approved
2012-033
VRTC Protocol No: ADX11080 - A
Non-Interventional Follow-Up to the
Velour study (multicentre International
Study of Aflibercept versus placebo in
combination with FOLFIRI for
metastatic colorectal cancer) Translational Research
Melanoma Institute Australia Biospecimen bank for melanoma
research
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
10-Dec-2012
Withdrawn
Associate Professor Michael Hughes
Northern Surgical Oncology
San Clinic Suite 404
185 Fox Valley Road
Wahroonga NSW 2076
12-Nov-2012
Approved
XL184-307: Phase 3 randomised
double blind controlled study of
Cabozanatinib (XL184) vs Prednisone
in metastatic castration resistant
prostate cancer patients who have
received prior Docetaxel and prior
Abiraterone or MDV3100 (COMET)
Implementation of an expanded midmeal menu service in an acute care
private hospital and its impact on
patients' nutritional intake and cost
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
29-Oct-2012
Approved
Ms Jodie Privett
Nutrition & Dietetics Department
Sydney Adventist Hospital
Wahroonga NSW 2076
29-Oct-2012
Approved
2012-029
Evaluation of the Integration of carer
knowledge to improve inpatient care
for dementia patients (TOP 5)
Dr Karen Luxford
Director, Patient Based Care
Clinical Excellence Commission
L 13, 227 Elizabeth Street
Sydney NSW 2000
12-Nov-2012
Approved
2012-028
GU09-145: Phase I/II Study of
BNC105P in Combination with
Everolimus or Following Everolimus
for Progressive Metastatic Clear Cell
Renal Cell Carcinoma Following Prior
Tyrosine Kinase Inhibitors
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
08-Oct-2012
Approved
2013-002
2012-032
2012-031
2012-030
Updated 1-Sep-2014
2012-027
FINESSE trial - Filtration in the
Neuropathy of End Stage Kidney
Disease Symptom Evolution. A
randomised, unblinded, controlled trial
to assess progression of neuropathy
with haemodiafiltration vs standard
haemodialysis in patients with
endstage kidney disease.
Data collection on outcomes on men
with prostate cancer treated with
radical prostatectomy
Dr Meg Jardine
The George Institute for Global
Health
PO Box M201
Missenden Road
Camperdown NSW 2050
15-May-2013
Approved
Associate Professor Henry Woo
Australian Clinical Trials Pty Ltd
Australian Clinical Trials
Suite 406 San Clinic
185 Fox Valley Road
Wahroonga NSW 2076
22-Oct-2012
Approved
2012-025
Data collection on outcomes on men
treated with greenlight laser surgery
Associate Professor Henry Woo
Australian Clinical Trials Pty Ltd
Australian Clinical Trials
Suite 406 San Clinic
185 Fox Valley Road
Wahroonga NSW 2076
10-Oct-2012
Approved
2012-024
A phase III study of the impact of a
physical activity program on diseasefree survival in patients with high risk
stage II or stage III colon cancer: a
randomised controlled trial
(CHALLENGE)
Living Well with Prostate Cancer: A
Randomised Controlled Trial of a
Mindfulness Intervention for Men with
Advanced Prostate Cancer
Development of Smart Phone
application for neuromuscular function
monitoring
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
26-Sep-2012
Approved
Professor Suzanne Chambers
553 Gregory Terrace
Fortitude Valley Qld 4006
26-Sep-2012
Approved
Dr Stephanie Phillips
Consultant Anaesthetist,
Sydney Adventist Hospital Clinical
School
406A San Clinic
185 Fox Valley Road
Wahroonga NSW 2076
26-Sep-2012
Approved
2012-021
An international survey on what
constitutes a large prostate
Associate Professor Henry Woo
Australian Clinical Trials Pty Ltd
Australian Clinical Trials
Suite 406 San Clinic
185 Fox Valley Road
Wahroonga NSW 2076
04-Sep-2012
Approved
2012-020
An Australian Translational Study to
Evaluate the Prognostic Role of
Inflammatory Markers in Patients with
Metastatic Colorectal Cancer Treated
with Bevacizumab (Avastin) [ASCENT]
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
05-Aug-2012
Approved
2012-019
FDC116115: A prospective study of
sexual function in sexually active men
treated for BPH
Associate Professor Henry Woo
Australian Clinical Trials Pty Ltd
Australian Clinical Trials
Suite 406 San Clinic
185 Fox Valley Road
Wahroonga NSW 2076
28-Nov-2012
Approved
2012-018
Has the introduction of baby friendly
caesarean section influenced breast
feeding rates at one and three months
post-natally?
A/Prof John Keogh
304 SAN Clinic
85 Fox Valley Road
WAHROONGA NSW 2076
2012-017
Can NSW Admitted Patient Data
improve the quality and coverage of
the NSW Register of Congenital
Conditions?
Dr Lee Taylor
Locked Bag 961
NSW Ministry of Health
Surveillance Methods Branch,
Centre of Epidemiology and
Research
North Sydney NSW 2059
2012-026
2012-023
2012-022
Archived - Never
Approved
24-Jul-2012
Approved
Updated 1-Sep-2014
2012-016
A phase II, double-blind, placebo
controlled, randomized study of GDC0941 or GDC-0980 with fulvestrant
versus fulvestrant in advanced or
metastatic breast cancer in patients
resistant to aromastase inhibitor
therapy (FERGI)
Involving relatives in the care of a
patient in the ICU setting; What factors
impact on this?
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
09-Jul-2012
Recruitment Ceased
Dr Tracey Thornley
Supervisor
Dean, School of Nursing Sydney
The University of Notre Dame
PO Box 944
Broadway NSW 2077
04-Jul-2012
Archived - Study Complete
The successfulness of ultrasound
guided removal of a Mirena device
when the strings are not visible on
speculum examination in an outpatient
setting (A retrospective review of
cases)
A multi-centre randomized controlled
trial of early goal-directed therapy in
patients presenting to the Emergency
Department with severe sepsis in
Australasia
Dr Karen Mizia
San Ultrasound for Women
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
30-Apr-2012
Study Complete
Dr Roger Harris
Staff Specialist,
Intensive Care,
Sydney Adventist Hospital,
185 Fox Valley Road
Wahroonga NSW 2076
16-May-2012
Archived - Study Complete
A randomised, open label, multicentre,
Phase IIIB study comparing two
Trastuzumab dosing regimens, each in
combination with Ciplatin/Capecitabine
chemotherapy, as first line therapy in
patients with HER2-positive metastatic
gastric or gastro-oesophageal junction
adenocarcinoma who have not
received prior treatment for metastatic
disease (HELOISE)
Assessment of spinal sagittal balance
parameters with EOS imaging
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
12-Mar-2012
Study Complete
Dr Peter Wilson
Neurosurgical trainee
1/241-245 Avoca Street
Randwick NSW 2031
18-Jun-2012
Approved
2012-010
Promotion of health lifestyle and risk
modification for cancer survivors and
their partners / caregivers (ENRICH:
Exercise and Nutrition Routine
Improving Cancer Health)
Dr Erica James
School of Medicine & Public Health
Faculty of Health
Level 2, David Maddison Building
Callaghan NSW 2308
12-Mar-2012
Approved
2012-009
Survey of nursing attitudes to residual
neuromuscular blockade and reversal
Dr Paul Stewart
AMO
Consultant Anaesthesia
05-Mar-2012
Approved
Jade Guest
28-Mar-2012
Approved
Mr Dallas O'Connor
Associate Director of Safe Place
Services
Seventh-day Adventist Church
(AUC) Ltd
PO Box 650
Wahroonga NSW 2076
12-Mar-2012
Approved
Professor Christine Clarke
Westmead Millennium Institute
Darcy Road
Westmead NSW 2145
20-Mar-2012
Approved
2012-015
2012-014
2012-013
2012-012
2012-011
PO Box 82
Wahroonga NSW 2076
2012-008
2012-007
The effect of high potency Omega-3
(Omacor) on markers of oxidative
stress and inflammation
Understanding clergy-parishioner
relationships in local congregational
settings - a qualitative analysis Phase 1
2012-006
Progesterone action in the human
breast
2012-005
Prospective Evaluation of Various
Uterine Prolapse Surgical Techniques
in Nepalii Women
A retrospective analysis of outcomes
following abdominal hysteropexy for
uterine prolapse in Nepal (Maharati 1)
2012-004
Archived - Withdrawn
Archived - Withdrawn
Updated 1-Sep-2014
2012-003
The Study of Heart and Renal
Protection - Extended Review SHARP-ER
Dr Meg Jardine
The George Institute for Global
Health
PO Box M201
Missenden Road
Camperdown NSW 2050
23-Apr-2012
Approved
2012-002
Designing a Prototype Clinical
Information System (CIS) for
Multidisciplinary Teams During Clinical
Handover in Palliative Oncology
Chris Williams
Chief Information Officer
Sydney Adventist Hospital
185 Fox Valley Rd
16-Jan-2012
Approved
Wahroonga NSW 2076
2012-001
Safety and Feasibility of a
Transurethral Endoscopic Procedure
for the Luminal Restoration of the
Prostatic Urethra: A Preliminary
Investigation
Associate Professor Henry Woo
Australian Clinical Trials Pty Ltd
Australian Clinical Trials
Suite 406 San Clinic
185 Fox Valley Road
Wahroonga NSW 2076
02-Feb-2012
Approved
2011-043
Evaluating the utility of a patient
decision aid for prospective
participants in the TROG RAVES
prostate cancer trial.
Associate Professor Henry Woo
Australian Clinical Trials Pty Ltd
Australian Clinical Trials
Suite 406 San Clinic
185 Fox Valley Road
Wahroonga NSW 2076
30-Jan-2012
Approved
2011-042
The complexity of treating women with
breast cancer, who have underlying
mental health issues.
Changing the system to increase the
adoption of "clot busters" in stroke
treatment
(TIPS)
Ms Catrina Ross
McGrath Breast Care Nurse
05-Dec-2011
Approved
Professor John Watson
Associate Dean
Sydney Adventist Hospital Clinical
School
28-Mar-2012
Approved
2011-040
Evaluation of a 12 week Yoga
Intervention on Negative Affective
States, Cardiovascular and Cognitive
Function in Post-Cardiac
Rehabilitation Patients
Prof Hosen Kiat
Medical Director SAH Cardiac
Rehabilitation Program
Cardiac Health Institute
173 Shaftsbury Road
Eastwood NSW 2122
13-Feb-2012
Approved
2011-039
Characterization of the acute
postprandial effect of energy dense
foods on key markers of oxidative
stress and inflammation
Associate Professor Ross Grant
CEO - Australasian Research
Institute
Chief Scientist
Australasian Research Institute
185 Fox Valley Road
Wahroonga NSW 2076
16-Jan-2012
Approved
2011-038
Arm-to-arm variation when evaluating
neuromuscular block: An analysis of
the precision and the bias and
agreement between arms when using
Electromyography in abductor digiti
minimi and first dorsal Interosseous.
Dr Paul Stewart
AMO
Consultant Anaesthesia
10-Oct-2011
Archived - Study Complete
Arm-to-arm variation when evaluating
neuromuscular block: An analysis of
the precision and the bias and
agreeement between arms when using
Kinemyography
Dr Paul Stewart
AMO
Consultant Anaesthesia
Retrospective Audit of Post-Operative
Analgesia after Ivor Lewis Oesophagogastrectomy
Dr Stephanie Phillips
Consultant Anaesthetist,
Sydney Adventist Hospital Clinical
School
406A San Clinic
185 Fox Valley Road
Wahroonga NSW 2076
2011-041
2011-037
2011-036
PO Box 82
Wahroonga NSW 2076
Archived - Study Complete
PO Box 82
Wahroonga NSW 2076
17-Oct-2011
Approved
Updated 1-Sep-2014
2011-035
Randomized, open Label Multi-Centre
Study Comparing Cabazitaxel at
20mg/m2 and at 25 mg/m2 Every 3
weeks in Combination with Prednisone
for the Treatment of Metastatic
Castration Resistant Prostate Cancer
Previously Treated with Docetaxel
Containing Regimen (PROSELICA).
Randomized, Open Label,
MultiCentre, Study comparing
Cabazitaxel at 25 mg/m2 and at 20
mg/m2 in Combination with
Prednisone Every 3 Weeks to
Docetaxel in Combination with
Prednisone in Patients with Metastatic
Castration Resistant Prostate Cancer
not Pre-treated with Chemotherapy
(FIRSTANA)
A randomized, double-blind, placebocontrolled, parallel group, multicenter
study to evaluate cardiovascular
outcomes during treatment with
Lixisenatide in type 2 diabetic patients
after an Acute Coronary Syndrome.
A phase III multi-centre, randomised
trial comparing adjuvant radiotherapy
(RT) with early salvage RT in patients
with positive margins or extraprostatic
disease following radical
prostatectomy (RAVES)
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
12-Sep-2011
Recruitment Ceased
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
12-Sep-2011
Recruitment Ceased
Dr Greg Fulcher
12-Sep-2011
Approved
Dr Amy Teh
Consultant in Radiation Oncology
Radiation Oncology Institute
Radiation Oncology Institute
185 Fox Valley Road
Wahroonga NSW 2076
30-Oct-2011
Approved
2011-031
To investigate the ten year retreatment rate after bladder neck
incision (BNI) or transurethral incision
of the prostate (TUIP) for outlet
obstruction.
Associate Professor Henry Woo
Australian Clinical Trials Pty Ltd
Australian Clinical Trials
Suite 406 San Clinic
185 Fox Valley Road
Wahroonga NSW 2076
05-Sep-2011
Approved
2011-030
Clinical study to evaluate a scaffold
implant for rotator cuff lesions
encountered on the supraspinatus
tendon (CIRCLES)
Associate Professor Desmond Bokor
Principal Investigator - SAH
Specialty Orthopaedics
116 Macquarie Street
Parramatta NSW 2150
05-Sep-2011
Approved
2011-029
An open label study of Abiraterone
Acetate in subjects with metastatic
castration-resistant prostate cancer
who have progressed after Taxanebased chemotherapy.
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
04-Jul-2011
Study Complete
2011-028
Incidence of residual neuromuscular
blockade in Australian post
anaesthetic care units
Dr Paul Stewart
AMO
Consultant Anaesthesia
18-Feb-2011
Approved
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
20-Jun-2011
Approved
Associate Professor Ross Grant
CEO - Australasian Research
Institute
Chief Scientist
Australasian Research Institute
185 Fox Valley Road
Wahroonga NSW 2076
29-Aug-2011
Approved
2011-034
2011-033
2011-032
PO Box 82
Wahroonga NSW 2076
2011-027
2011-026
A Phase 3, Randomized, Double-blind,
Multicenter Trial Comparing Orteronel
(TAK-700) Plus Prednisone With
Placebo Plus Prednisone in Patients
With Metastatic Castration-Resistant
Prostate Cancer that has progressed
During or Following Docetaxel-based
Therapy.
The pharmacokinetic differences in
serum and saliva levels of resveratrol,
lycopene complex, NAD+ and
oxidative stress.
Updated 1-Sep-2014
2011-025
Do whole and/or highly processed
foods or food ingredients promote
adverse physiological responses?
Associate Professor Ross Grant
CEO - Australasian Research
Institute
Chief Scientist
Australasian Research Institute
185 Fox Valley Road
Wahroonga NSW 2076
2011-024
Improving psychosocial outcomes for
carers of people with cancer: a
randomised controlled trial
Dr Joanne Shaw
Surgical Outcomes Research Centre
Building 89 Level 9
PO Box M157
Missenden Road NSW 2050
20-Jun-2011
Approved
2011-023
A Phase 3, randomized, double-blind
trial of Pegylated Liposomal
Doxorubicin (PLD) plus AMG 386 or
placebo in women with recurrent
partially platinum sensitive or resistant
epithelial ovarian, primary peritoneal or
fallopian tube cancer.
Direct intra-patient comparison of
evoked electromyography and
acceleromyography during induced
neuromuscular blockade in
anaesthetised humans.
Dr Joseph Rutovitz
San Clinical Trials Unit
Adventist HealthCare Limited
185 Fox Valley Road
Wahroonga NSW 2076
13-Jun-2011
Approved
Dr Paul Stewart
AMO
Consultant Anaesthesia
14-Jun-2011
Approved
Direct intra-patient comparison of
evoked electromyography and
kinemyography during induced
neuromuscular blockade in
anaesthetised humans.
Dr Paul Stewart
AMO
Consultant Anaesthesia
14-Jun-2011
Approved
2011-020
Comparison of evoked
electromyographic responses in three
different muscle groups of the hand
following induced muscle relaxation in
humans under general anaesthesia.
Dr Stephanie Phillips
Consultant Anaesthetist,
Sydney Adventist Hospital Clinical
School
406A San Clinic
185 Fox Valley Road
Wahroonga NSW 2076
14-Jun-2011
Study Complete
2011-019
Comparison of gastric volumes and pH
in lean and obese patients, determined
by endoscopy.
Dr Stephanie Phillips
Consultant Anaesthetist,
Sydney Adventist Hospital Clinical
School
406A San Clinic
185 Fox Valley Road
Wahroonga NSW 2076
14-Jun-2011
Approved
2011-018
PREVAIL: A multinational Phase 3,
randomized, double-blind placebocontrolled efficacy and safety study of
oral MDV3100 in chemotherapy-naive
patients with progressive metastatic
prostate cancer who have failed
androgen deprivation therapy
(MDV3100-03)
Current practice of neuro-muscular
blockade in Australia. A crosssectional survey of attitudes and
practice of anaesthetists in 2011.
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
30-May-2011
Recruitment Ceased
Dr Stephanie Phillips
Consultant Anaesthetist,
Sydney Adventist Hospital Clinical
School
406A San Clinic
185 Fox Valley Road
Wahroonga NSW 2076
06-Jun-2011
Study Complete
2011-016
Bi-National Colorectal Cancer Audit
Dr Stuart Pincott
06-Jun-2011
Approved
2011-015
Multicentre, single-arm, open label,
clinical trial intended to provide early
access to Cabazitaxel in patients with
metastatic hormone refractory prostate
cancer previously treated with a
Docetaxel-containing regimen and to
document safety of Cabazitaxel in
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
09-May-2011
Study Complete
2011-022
2011-021
2011-017
Archived - Rejected
PO Box 82
Wahroonga NSW 2076
PO Box 82
Wahroonga NSW 2076
Updated 1-Sep-2014
these patients (Cabazitaxel clinical
trial)
2011-014
Phase II study to investigate the ability
of macrophage inhibitory cytokine-1
(MIC-1) and associated plasma
biomarkers to predict response to
chemotherapy in patients with
metastatic hormone-refractory prostate
cancer.
The Australian diabetes, obesity and
lifestyle study
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
19-Apr-2011
Approved
Dr Elizabeth Barr
Epidemiologist Baker IDI Heart &
Diabetes Institute
Tues/Frid
20-Apr-2011
Approved
2011-012
Attitudes of SAN community to clinical
student teaching in a private hospital
setting
Dr Stephanie Phillips
Consultant Anaesthetist,
Sydney Adventist Hospital Clinical
School
406A San Clinic
185 Fox Valley Road
Wahroonga NSW 2076
11-Apr-2011
Study Complete
2011-011
Porto Cath insertion
Dr Sumit Lumba
Medical Oncology Advanced Trainee
under Dr Eisen Liang and Dr Gavin
Marx
2011-010
Grounded theory research
investigating organisational change in
specified Australian hospitals to
determine the applicability of existing
generic organisational change
management models to the not-forprofit hospital environment.
Randomised controlled double-blind
trial of targeted intra-crural ropivicaine
for post-operative analgesia after
laparoscopic fundoplication.
Prof Elizabeth More
PhD Supervisor
2011-008
A pilot study to evaluate a new blood
test for the detection of prostate
cancer using antibody arrays.
Associate Professor Henry Woo
Australian Clinical Trials Pty Ltd
Australian Clinical Trials
Suite 406 San Clinic
185 Fox Valley Road
Wahroonga NSW 2076
30-May-2011
Approved
2011-007
Rhinology Tissue Bank
A/Prof Richard Harvey
St Vincent's Hospital
Sydney Ear Nose & Throat Clinic
Sydney Ear Nose & Throat Clinic
354 Victoria Street
Darlinghurst NSW 2010
11-Jul-2011
Approved
2011-006
Assessment of the effect of oral
supplementation with resveratrol
and/or lycopene on key markers of
oxidative stress over time and skin
health following acute UV exposure.
Associate Professor Ross Grant
CEO - Australasian Research
Institute
Chief Scientist
Australasian Research Institute
185 Fox Valley Road
Wahroonga NSW 2076
06-Jun-2011
Archived - Study Complete
2011-005
Quantification of key markers of
oxidative stress and inflammation in
human cerebrospinal fluid and
correlation with diet, lifestyle and
psychosocial factors across the age
range: Part 2.
Associate Professor Ross Grant
CEO - Australasian Research
Institute
Chief Scientist
Australasian Research Institute
185 Fox Valley Road
Wahroonga NSW 2076
24-May-2011
Approved
2011-013
2011-009
Archived - Study Complete
30-May-2011
Dr Stephanie Phillips
Consultant Anaesthetist,
Sydney Adventist Hospital Clinical
School
406A San Clinic
185 Fox Valley Road
Wahroonga NSW 2076
Approved
Archived - Abandoned
Updated 1-Sep-2014
2011-004
Incidence and management of
capnothorax during laparoscopic
massive hiatus hernia repair.
2011-003
No study submitted
2011-002
Patterns of care in patients with
pancreatic cancer (POCS Pancreas
NSW).
Dr Stephanie Phillips
Consultant Anaesthetist,
Sydney Adventist Hospital Clinical
School
406A San Clinic
185 Fox Valley Road
Wahroonga NSW 2076
21-Feb-2011
Study Complete
Archived - Never
Approved
Prof Dianne O’Connell
Senior Epidemiologist,
Cancer Council NSW
25-Jan-2011
Approved
Cancer Council
PO Box 572
Kings Cross NSW 1340
2011-001
Cell type specific biologic responses to
HIV infection
Professor Anthony Cunningham
Westmead Millennium Institute
Westmead Millennium Institute for
Medical Research
PO Box 412
Westmead NSW 2145
19-Jan-2011
Approved
28/10
Study to assess the incidence and
efficacy of treatment of Helicobacter
pylori infection in a representative
population from the Gyuto Monastery
in Northern India.
Associate Professor Ross Grant
CEO - Australasian Research
Institute
Chief Scientist
Australasian Research Institute
185 Fox Valley Road
Wahroonga NSW 2076
08-Dec-2010
Archived - Study Complete
27/10
A randomized, multicentre, open-label,
Phase 3 study to compare the efficacy
and safety of Panitumumab and
Cetuximab in subjects with previously
treated, wild-type KRAS, metastatic
colorectal cancer.
Establishment of a neuro and
endocrine tumour and tissue bank
within the Department of Cancer
Genetics, Kolling Institute and the
University of Sydney Endocrine
Surgical Unit.
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
10-Dec-2010
Study Complete
Professor Bruce Robinson
The University Clinic
Wallace Freeborn Professorial
Block,
Royal North Shore Hospital
St Leonards NSW 2065
13-Dec-2010
Approved
25/10
Age related changes in NAD+
metabolism, oxidative stress and
Sirtuin activity in human muscle.
Associate Professor Ross Grant
CEO - Australasian Research
Institute
Chief Scientist
Australasian Research Institute
185 Fox Valley Road
Wahroonga NSW 2076
08-Dec-2010
Archived - Study Complete
24/10
A prospective non-interventional study
to evaluate the effect of Triptorelin
Embonate (Diphereline 11.25mg) on
lower urinary tract symptoms (LUTS)
in Australian prostate cancer patients.
Associate Professor Henry Woo
Australian Clinical Trials Pty Ltd
Australian Clinical Trials
Suite 406 San Clinic
185 Fox Valley Road
Wahroonga NSW 2076
25-Jan-2011
Approved
23/10
PREVAIL: A multinational Phase 3,
randomized, double-blind, placebocontrolled efficacy and safety study of
oral MDV3100 in chemotherapy-naïve
patients with progressive metastatic
prostate cancer who have failed
androgen deprivation therapy
(MDV3100-03)
Identification of plasma biomarkers of
therapeutic response in men with
metastatic castrate-resistant prostate
cancer (Biomarkers in Metastatic
CRPC)
Associate Professor Henry Woo
Australian Clinical Trials Pty Ltd
Australian Clinical Trials
Suite 406 San Clinic
185 Fox Valley Road
Wahroonga NSW 2076
02-Feb-2011
Approved
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
05-Sep-2010
Approved
26/10
22/10
Updated 1-Sep-2014
21/10
Cancer multidisciplinary team research
project.
Dr Genevieve Baratiny
Visiting Research Fellow
Discipline of General Practice,
University of Adelaide
North Terrace SA 5005
22-Sep-2010
Approved
20/10
A randomized, double-blind, placebocontrolled, multi-centre phase 3 study
of Denosumab as adjuvant treatment
for women with early-stage breast
cancer at high risk of recurrence (DCare)
Advisa Dr MRI pacing system clinical
study.
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
23-Aug-2010
Recruitment Ceased
18/10
Modular-choice secondary prevention
following acute coronary syndrome: a
randomised multicentre trial.
Dr Julie Redfern
Senior Research Fellow
The George Institute for Global
Health,
PO Box M201 Missenden Road
NSW 2050
15-Jul-2010
Approved
17/10
Pilot study to assess the efficacy of
naturally enhanced soy powder to
reduce fasting blood glucose levels in
humans.
Associate Professor Ross Grant
CEO - Australasian Research
Institute
Chief Scientist
Australasian Research Institute
185 Fox Valley Road
Wahroonga NSW 2076
30-Jun-2010
Study Complete
16/10
A multicentre, controlled trial to
determine the safety and efficacy of
hypertensive extracorporeal limb
perfusion (HELP) in treating patients
with critical limb ischaemia.
Improved cord blood stem cell
recovery through the characterization
of upstream factors contributing to final
post thaw viability – Part II.
Professor Rodney Lane
Suite 13 Greenwich Square,
130-134 Pacific Highway
St Leonards NSW 2065
30-Jun-2010
Archived - Discontinued
Belinda Pope
Quality Manager
Stem Cell Unit,
L5 Pathology,
Sydney Adventist Hospital,
185 Fox Valley Road
Wahroonga NSW 2076
30-Jun-2010
Approved
14/10
Clinical results of dynamic hip screws
versus proximal femoral nails for
intratrochanteric fractures.
A/Prof Nigel Hope
Suite 11,
4 Young St
Neutral Bay NSW 2089
08-Jun-2010
Approved
13/10
Assessment of senior adults in
oncology. A prospective audit of
clinical practice in Australian oncology
units.
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
31-May-2010
Approved
12/10
Establishing the factors that contribute
to a shortfall in evidence-based
radiotherapy.
Prof Geoff Delaney
Director Radiation Oncology,
Western Zone,
Sydney South West Area Health
Service
Liverpool Hospital Cancer Therapy
Centre,
Locked Bag 7103
Liverpool BC NSW 1871
24-May-2010
Approved
11/10
A Randomized Double-Blind Phase 3
Trial Comparing Docetaxel Combined
with Dasatinib to Docetaxel Combined
with Placebo in Castration-Resistant
Prostate Cancer.
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
03-May-2010
Discontinued
19/10
15/10
Dr Peter Illes
502 San Clinic
185 Fox Valley Road
Wahroonga NSW 2076
Archived - Rejected
Updated 1-Sep-2014
10/10
The impact of San Day Infusion Centre
treatment on the experience of pain,
anxiety, nausea and fatigue in cancer
patients.
Ms Anne Temblett
Director of Medical Care Services
(Nursing)
185 Fox Valley Road
Wahroonga NSW 2076
23-Apr-2010
Approved
09/10
Consumer perspectives regarding
dialysis treatment.
Dr Paul Collett
Director of Nephrology
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
13-Apr-2010
Approved
08/10
Validation study of recurrent
postpartum haemorrhage and
associated factors as reported in the
admitted patient data collection and
midwives data collections 2002-2006
(validated against medical records).
Dr Jane Ford
University of Sydney,
Dept of Obstetrics & Gynaecology,
Level 2,
Building 52,
Royal North Shore Hospital
St Leonards NSW 2065
15-Jun-2010
Approved
07/10
Patient Journey Review
Lillian Stibbs
Quality Management Officer,
San Day Surgery Hornsby,
c/o 22 Moolanda Avenue
West Pennant Hills NSW 2126
29-Mar-2010
Approved
06/10
Prayer request form study
Ms Kristina Mazzaferri
Senior Chaplain
Sydney Adventist Hospital,
185 Fox Valley Road
Wahroonga NSW 2076
29-Mar-2010
Approved
05/10
Improved cord blood stem cell
recovery through the characterization
of upstream factors contributing to final
post thaw viability.
Belinda Pope
Quality Manager
Stem Cell Unit,
L5 Pathology,
Sydney Adventist Hospital,
185 Fox Valley Road
Wahroonga NSW 2076
26-Feb-2010
Approved
04/10
A multi-centre, prospective controlled
trial on the incidence of retrograde
ejaculation post photoselective
vaporisation prostatectomy (PVP)
compared to diathermy transurethral
resection of the prostate (TURP).
Associate Professor Henry Woo
Australian Clinical Trials Pty Ltd
Australian Clinical Trials
Suite 406 San Clinic
185 Fox Valley Road
Wahroonga NSW 2076
24-Mar-2010
Approved
03/10
The IMPACT of Biotronik home
monitoring guided anticoagulation on
stroke risk in patients with ICD and
CRT-D devices.
Dr Peter Illes
502 San Clinic
185 Fox Valley Road
Wahroonga NSW 2076
30-Jun-2010
Archived - Discontinued
02/10
Health-related outcomes of valve
surgery for rheumatic heart disease
performed by a volunteer humanitarian
team in Fiji.
Dr Robyn Gallagher
University of Technology,
Sydney
University of Technology
Level 7, Building 10 City Campus
PO Box 123
03-Feb-2010
Approved
30-Jun-2010
Approved
BROADWAY NSW 2007
01/10
A preliminary investigation into primary
causes of oxidative stress in the brain
and its impact on vital neuronal cell
biochemistry.
Associate Professor Ross Grant
CEO - Australasian Research
Institute
Chief Scientist
Australasian Research Institute
185 Fox Valley Road
Wahroonga NSW 2076
Updated 1-Sep-2014
25/09
Ovarian cancer patterns of care survey
– NSW
A/Prof Penelope Webb
Queensland Institute of Medical
Research,
Cancer & Population Studies Unit,
PO Royal Brisbane Women’s
Hospital
Herston QLD 4029
14-Dec-2009
Approved
24/09
AG0507GS: A multicentre phase II
study of Risk Evaluation in GIST with
Selective Therapy Escalation for
Response. (REGISTER)
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
30-Nov-2009
Archived - Discontinued
23/09
Cancer incidence in recipients of
haematopoietic stem cell
transplantation in Australia
Dr Lesley Ashton
Children’s Cancer Institute Australia,
PO Box 81
Randwick NSW 2032
01-Dec-2009
Approved
22/09
Investigation into the effect of patient
body habitus on quality of mesorectal
resection in rectal cancer.
A Phase 3, randomized, double-blind,
placebo-controlled study of
Abiraterone Acetate (CB7630) plus
Prednisone in asymptomatic or mildly
symptomatic patients with metastatic
castration-resistant prostate cancer
(COUGAR-AA-302)
Case studies with muscle relaxants
reversal agents.
Dr Adrian Smith
09-Nov-2009
Approved
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
04-Nov-2009
Recruitment Ceased
Dr Paul Stewart
AMO
Consultant Anaesthesia
27-Oct-2009
Approved
21/09
20/09
PO Box 82
Wahroonga NSW 2076
19/09
The Australian Maternity Outcomes
Surveillance System (AMOSS):
Improving the safety and quality of
maternity care in Australia.
Professor Elizabeth Sullivan
Associate Dean (Research)
University of Technology, Sydney,
Faculty of Health
Faculty of Health
University of Technology, Sydney
Broadway NSW 2077
10-Mar-2010
Approved
18/09
Pilot study to assess the incidence and
efficacy of treatment of Helicobacter
pylori infection in a representative
population from the Gyuto Monastery
in Northern India.
Associate Professor Ross Grant
CEO - Australasian Research
Institute
Chief Scientist
Australasian Research Institute
185 Fox Valley Road
Wahroonga NSW 2076
14-Oct-2009
Archived - Study Complete
17/09
Early parenteral nutrition versus
standard care in the critically ill patient:
A level I randomised controlled trial.
Dr Roger Harris
Staff Specialist,
Intensive Care,
Sydney Adventist Hospital,
185 Fox Valley Road
Wahroonga NSW 2076
14-Oct-2009
Archived - Study Complete
16/09
A double-blind, placebo-controlled
study to evaluate new or worsening
lens opacifications in subjects with
non-metastatic prostate cancer
receiving Denosumab for bone loss
due to androgen-deprivation therapy.
Associate Professor Henry Woo
Australian Clinical Trials Pty Ltd
Australian Clinical Trials
Suite 406 San Clinic
185 Fox Valley Road
Wahroonga NSW 2076
14-Oct-2009
Approved
15/09
A Phase III, randomised, placebocontrolled, double-blind study to
assess the efficacy and safety of onedaily orally administered ZD4054
10mg in non-metastatic hormoneresistant prostate cancer patients.
Associate Professor Henry Woo
Australian Clinical Trials Pty Ltd
Australian Clinical Trials
Suite 406 San Clinic
185 Fox Valley Road
Wahroonga NSW 2076
14-Oct-2009
Archived - Study Complete
Updated 1-Sep-2014
14/09
A double-blind, randomised, multiple
dose, phase III, multicentre study of
Alpharadin in the treatment of patients
with symptomatic hormone refractory
prostate cancer with skeletal
metastases.
Associate Professor Henry Woo
Australian Clinical Trials Pty Ltd
Australian Clinical Trials
Suite 406 San Clinic
185 Fox Valley Road
Wahroonga NSW 2076
14-Oct-2009
Archived - Study Complete
12/09
A prospective, randomized, doubleblind, placebo-controlled Phase III
study of Modafinil to improve fatigue
and quality of life (QOL) in patients
treated with Docetaxel-based
chemotherapy for metastatic breast or
prostate cancer – MOTIF (Modafinil in
Taxotere® - Induced Fatigue).
Botox injection for treatment of chronic
prostate pain
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
14-Aug-2009
Archived - Study Complete
10/09
The NSW Cancer, Lifestyle and
Evaluation of Risk (CLEAR) study.
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
27-Jul-2009
Archived - Study Complete
09/09
Continuous ST segment monitoring
and incidence of clinical events in ICD
patients – AnalyST Registry
Dr Peter Illes
502 San Clinic
185 Fox Valley Road
Wahroonga NSW 2076
06-Jul-2009
Archived - Abandoned
08/09
An observational, multicentre, open
label, non-interventional programme to
assess the long-term safety and
efficacy of Somatuline® Autogel® in
the treatment of NET when
administered by patients or their
partners (“home injection group”) or
administered by healthcare
professionals.
Prediction of cardiotoxicity by
measurement of serum N-terminal proB-type natriuretic peptide levels in
breast cancer patients receiving
adjuvant Trastuzumab (CATS)
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
06-Jul-2009
Archived - Study Complete
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
08-Jun-2009
Approved
A Phase Ib/II study to assess the
safety and efficacy of AMG102 in
combination with Mitoxantrone and
Prednisone in subjects with previously
treated castrate resistant prostate
cancer (AMG102)
A multi-centre, randomized, doubleblind, phase 3 study of sunitinib plus
prednisone versus prednisone in
patients with progressive metastatic
hormone-refractory prostate cancer
after failure of a docetaxel-based
chemotherapy regimen.
Characterisation of the effect of
polyphenol fortified red grape juice on
markers of oxidative stress and redox
potential in healthy human subjects.
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
11-May-2009
Archived - Study Complete
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
11-May-2009
Archived - Study Complete
Ms Hemani Trevidi
Dept Pharmacology,
University of NSW,
203 Wallace Wurth Building
13-May-2009
Archived - Study Complete
Consumer Forums conducted by
Marketing, Communications &
Business Development Unit
Ms Julie Behrens
Group Director Marketing &
Business Development
18-Mar-2009
Approved
11/09
07/09
06/09
05/09
04/09
03/09
Associate Professor Henry Woo
Australian Clinical Trials Pty Ltd
Australian Clinical Trials
Suite 406 San Clinic
185 Fox Valley Road
Wahroonga NSW 2076
Adventist HealthCare Limited
185 Fox Valley Road
Wahroonga NSW 2076
Archived - Abandoned
Updated 1-Sep-2014
02/09
01/09
33/08
32/08
31/08
30/08
29/08
28/08
27/08
26/08
ACTIVE dialysis – A Clinical Trial of
IntensiVE Dialysis. A multicentre,
unblended, randomised, controlled trial
to assess quality of life, clinical
outcomes and cost utility for extended
vs standard duration of dialysis in
patients with end stage kidney disease
Long-term follow-up of efficacy of
transurethral resection of the prostate.
Dr Paul Collett
Director of Nephrology
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
01-Jul-2009
Study Complete
Associate Professor Henry Woo
Australian Clinical Trials Pty Ltd
Australian Clinical Trials
Suite 406 San Clinic
185 Fox Valley Road
Wahroonga NSW 2076
22-Mar-2009
Archived - Study Complete
A multicentre, open-label, randomised,
phase III trial comparing immediate
adjuvant hormonal therapy (Eligard –
leuprolide acetate)) in combination
with Taxotere (cocetaxel) administered
every three weeks versus hormonal
therapy alone versus deferred therapy
followed by the same therapeutic
options in patients with prostate
cancer at high risk of relapse after
radical prostatectomy.
A phase III randomised study of
Brivanib Alaninate (BMS 582664) in
combination with Cetuximab (Erbitux,
C225) versus placebo in combination
with Cetuximab in patients previously
treated with combination
chemotherapy for metastatic colorectal
carcinoma.
A randomized, double-blind,
multicentre study of denosumab
compared with zoledronic acid
(Zometa) in the treatment of bone
metastases in subjects with advanced
breast cancer.
A Phase III, randomised, double-blind
study to assess the efficacy and safety
of 10mg ZD4054 versus placebo in
patients with hormone resistant
prostate cancer and bone metastasis
who are pain free or mildly
symptomatic.
RIBBON study – A Phase III
multicentre, randomised, placebocontrolled trial evaluating the efficacy
and safety of Bevacizumab in
combination with chemotherapy
regimens in subjects with previously
treated metastatic breast cancer.
A randomized, double-blind,
multicentre, Phase III study to
compare the efficacy and safety of
AZD2171 when added to 5fluorouracil, leucovorin and oxaliplatin
(FOLFOX) or capecitabine and
oxaliplatin (XELOX) with the efficacy
and safety of placebo when added to
FOLFOX or XELOX in patients with
previously untreated metastatic
colorectal cancer. Protocol
D8480C0051
A Phase 3, multicentre, randomized,
placebo-controlled, double-blind trial of
AMG 706 in combination with
Paclitaxel and Carboplatin for
advanced non-small cell lung cancer.
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
01-Apr-2008
Archived - Study Complete
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
01-Apr-2008
Archived - Study Complete
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
01-Apr-2008
Archived - Study Complete
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
01-Apr-2008
Archived - Study Complete
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
01-Apr-2008
Archived - Study Complete
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
01-Apr-2008
Archived - Study Complete
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
01-Apr-2008
Archived - Study Complete
A multicentre, randomized, doubleblind study comparing the efficacy and
safety of aflibercept versus placebo
administered every 3 weeks in patients
treated with Docetaxel/Prednisone for
metastatic androgen-independent
prostate cancer.
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
01-Apr-2008
Archived - Study Complete
Updated 1-Sep-2014
25/08
24/08
23/08
22/08
21/08
20/08
19/08
18/08
17/08
16/08
15/08
A double-blind, randomised,
multicentre, Phase III study of
Bevacizumab in combination with
Capecitabine and Cisplatin versus
placebo in combination with
Capecitabine and Cisplatin, as firstline therapy in patients with advanced
gastric cancer.
A phase III open label, randomized,
two-parallel-arm multicentre study of
E7389 versus Capecitabine in patients
with locally advanced or metastatic
breast cancer previously treated with
anthracyclines and taxanes and
refractory to the most recent
chemotherapy.
A randomised, double-blind,
multicentre study of denosumab
compared with zoledronic acid
(Zometa) in the treatment of bone
metastases in subjects with advanced
cancer (Excluding breast and prostate
cancer) or multiple myeloma.
A randomized, double-blind, multicentre study of Denosumab compared
with Zoledronic Acid (Zometa) in the
treatment of bone metastases in men
with hormone-refractory prostate
cancer.
A randomised, open-label, multicentre
study to evaluate the efficacy and
safety of Bevacizumab in combination
with Trastuzumab/Docetaxel
compared with
Trastuzumab/Docetaxel alone as first
line treatment for patients with HER2
positive locally recurrent or metastatic
breast cancer.
A randomised, multi-centre, Phase 3
study to compare the efficacy of
panitumumab in combination with
chemotherapy to the efficacy of
chemotherapy alone in patients with
previously treated metastatic
colorectal cancer.
A randomised double-blind, placebocontrolled, multi-centre Phase 3 study
of Denosumab on prolonging bone
metastasis-free survival in men with
hormone- refractory prostate cancer.
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
01-Apr-2008
Archived - Study Complete
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
01-Apr-2008
Approved
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
01-Apr-2008
Archived - Study Complete
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
01-Apr-2008
Archived - Study Complete
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
01-Apr-2008
Approved
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
01-Apr-2008
Archived - Study Complete
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
01-Apr-2008
Archived - Study Complete
A prospective, multicentre,
randomized trial of carboplatin flat
dosing versus intrapatient dose
escalation in first line chemotherapy of
ovarian fallopian tube and primary
peritoneal cancers.
A multinational, randomised, doubleblind study comparing the efficacy of
Afibercept once every 2 weeks versus
placebo in patients with metastatic
colorectal cancer (MCRC) treated with
Irinotecan / 5-FU combination
(FOLFIRI) after failure of Oxaliplatin
based regimen.
Chronic cough without wheeze or
shortness of breath in children may be
caused by upper airway obstruction
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
01-Apr-2008
Archived - Discontinued
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
01-Apr-2008
Archived - Study Complete
Dr Hugh Allen
Dept of Paediatrics,
Royal North Shore Hospital ,
Pacific Highway
St Leonards NSW 2065
19-Dec-2008
Archived - Study Complete
Influence of home monitoring on
mortality and morbidity in heart failure
patients with an impaired left
ventricular function (IN-TIME)
Dr Peter Illes
502 San Clinic
185 Fox Valley Road
Wahroonga NSW 2076
28-Jan-2009
Archived - Study Complete
Updated 1-Sep-2014
14/08
A randomised, double-blind, placebocontrolled, factorial-design trial to
assess the effect of aspirin and fish oil
(omega-3 fatty acids) in the prevention
of early thrombosis in arterio-venous
fistulae in patients with Stage IV or V
chronic kidney disease requiring
haemodialysis (FAVOURED)
Temporal trends in incidence of
primary brain tumours in the Australian
Capital Territory and New South
Wales: 1994 – 2008
Dr Paul Collett
Director of Nephrology
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
03-Dec-2008
Approved
Dr Vini Khurana
Dept of Neurosurgery,
The Canberra Hospital,
PO Box 11
Woden ACT 2606
29-Jan-2009
Archived - Study Complete
A randomized, double-blind,
multicentre, phase II/III study to
compare the efficacy of AZD2171 in
combination with 5-fluorouracil,
leucovorin and oxaliplatin (FOLFOX),
to the efficacy of bevacizumab in
combination with FOLFOX in patients
with previously untreated metastatic
colorectal cancer. Protocol No:
D8480C00013
Haemostasis Registry
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
23-Oct-2008
Archived - Study Complete
Prof Peter Cameron
Haemostasis Registry,
Dept of Epidemiology & Preventive
Medicine,
Monash University,
The Alfred Hospital,
Commercial Road
Melbourne VIC 3004
10-Oct-2008
Archived - Study Complete
10/08
Optimal programming to improve
mechanical indices, symptoms and
exercise in cardiac resynchronization
therapy (OPTIMISE CRT)
Dr Peter Illes
502 San Clinic
185 Fox Valley Road
Wahroonga NSW 2076
09/08
A phase II biomarker identification trial
for Erlotinib (Tarceva) in patients with
advanced pancreatic carcinoma.
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
10-Sep-2008
Archived - Study Complete
08/08
A phase II, dose escalation to rash trial
of Erlotinib (Tarceva) plus
Gemcitabine in patients with
metastatic pancreatic cancer.
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
10-Sep-2008
Archived - Study Complete
07/08
Age at first birth, mode of conception
and adjustment to parenthood.
Dr Catherine McMahon
Senior Lecturer Psychology
Psychology Dept,
Macquarie University
North Ryde NSW 2109
03-Sep-2008
Archived - Study Complete
06/08
Neurobiological correlates of
depression in adolescents.
Associate Professor Ross Grant
CEO - Australasian Research
Institute
Chief Scientist
Australasian Research Institute
185 Fox Valley Road
Wahroonga NSW 2076
27-Aug-2008
Archived - Study Complete
05/08
A phase 3 , randomised double-blind
placebo controlled study of Abiratone
Acetate (CB7630) plus prednisone in
patients with metastatic castrationresistant prostate cancer who have
failed Docetaxel-based chemotherapy.
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
14-Aug-2008
Archived - Study Complete
13/08
12/08
11/08
Archived - Withdrawn
Updated 1-Sep-2014
04/08
Phase I, single-centre, randomised,
placebo controlled, fixed dose clinical
trial of the safety and efficacy of up to
14 days application of Zb extract
cream in the treatment of subjects with
common warts.
Associate Professor Ross Grant
CEO - Australasian Research
Institute
Chief Scientist
Australasian Research Institute
185 Fox Valley Road
Wahroonga NSW 2076
14-May-2008
Archived - Discontinued
03/08
To assess a level of satisfaction with
PageWriter TC70 (VersionA.01.00)
cardiograph and the Triton PIM lead
set for its functionality and
performance
An international multi-centre openlabel 2-arm phase III trial of adjuvant
Bevacizumab in triple negative breast
cancer - BEATRICE
Penman
Director of Patient Flow Services
Sydney Adventist Hospital
22-May-2008
Archived - Study Complete
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
09-Apr-2008
Recruitment Ceased
01/08
Neuro and Endocrine Tumour and
Tissue Bank
Dr Diana Benn
Senior Research Scientist
Cancer Genetics Unit,
Kolling Institute of Medical
Research,
Royal North Shore Hospital
St Leonards NSW 2065
09-Apr-2008
Archived - Study Complete
20/07
ACTIVE Dialysis – A Clinical Trial of
IntensiVE Dialysis
Dr Paul Collett
Director of Nephrology
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
12-Dec-2007
Archived - Study Complete
19/07
CoolCath Trial – An international study
to assess the safety and efficacy of the
CoolMaxTM microwave catheter.
Associate Professor Henry Woo
Australian Clinical Trials Pty Ltd
Australian Clinical Trials
Suite 406 San Clinic
185 Fox Valley Road
Wahroonga NSW 2076
12-Dec-2007
Archived - Withdrawn
18/07
Bed Head Elevation Study
Dr Ian Baldwin
145 Studley Rd
Heidelberg VIC 3084
12-Dec-2007
Archived - Withdrawn
17/07
Quantification of NAD+ levels in
normal human plasma: correlation with
age and oxidative stress.
Associate Professor Ross Grant
CEO - Australasian Research
Institute
Chief Scientist
Australasian Research Institute
185 Fox Valley Road
Wahroonga NSW 2076
12-Dec-2007
Approved
16/07
Does a tea-tree cleansing foam effect
the bacterial flora of chronic leg ulcer
wounds: a preliminary investigation.
Gary Bain
Wound Clinic,
Sydney Adventist Hospital,
185 Fox Valley Road
Wahroonga NSW 2076
12-Dec-2007
Archived - Study Complete
15/07
Development of a semen-based test
for prostate cancer.
Associate Professor Henry Woo
Australian Clinical Trials Pty Ltd
Australian Clinical Trials
Suite 406 San Clinic
185 Fox Valley Road
Wahroonga NSW 2076
12-Dec-2007
Archived - Discontinued
14/07
Automated Pacemaker Home
Monitoring Reduces the Need for
Regular Routine Clinic Checks
Health services innovation grant for
the employment of a patient navigator
– breast cancer.
Dr Jason Sharp
29-Apr-2008
Archived - Study Complete
Dr Barbara Newman
Patient Navigator,
Clinical Services,
Sydney Adventist Hospital,
185 Fox Valley Road
Wahroonga NSW 2076
31-Oct-2007
Archived - Study Complete
02/08
13/07
Updated 1-Sep-2014
12/07
Portacath Survey
Eisen Liang
San Radiology
11/07
Breast Cancer Tissue Bank
Professor Christine Clarke
Westmead Millennium Institute
Darcy Road
Westmead NSW 2145
05-Sep-2007
Approved
10/07
An inquiry into the development of
support groups and their effects on the
well-being of people with lung and
gynaecological cancer and their
carers.
Sally Goss
Project Coordinator,
Lung & Gynaecological Cancer
Support,
Cancer Support Centre,
Sydney Adventist Hospital,
185 Fox Valley Road
Wahroonga NSW 2076
10-Aug-2007
Archived - Withdrawn
09/07
International Survey of patients with
chronic pain: their experience of pain.
Wendy White
Clinical Nurse Consultant,
Monash University,
Wound Foundation of Australia,
NSW Branch,
PO Box 4665
Lake Haven NSW 2263
09-May-2007
Archived - Study Complete
08/07
Measuring impact on patient nutritional
status in the highly dependent patient
before and after the implementation of
a feeding team*: “a focus on highly
dependent patients”
Sarah Liston
Manager Dietetics,
Sydney Adventist Hospital,
185 Fox Valley Road
Wahroonga NSW 2076
30-May-2007
Archived - Study Complete
07/07
A 12-month double-blind, randomized,
multicenter, active-controlled, parallelgroup study comparing the efficacy
and safety of 0.5mg and 1.25mg
fingolimod (FTY 720) administered
orally once daily versus interferon B1a (Avonex ®)administered i.m. once
weekly in patients with relapsingremitting multiple sclerosis.
(TRANSFORMS)
Proof of concept: an open label pilot
study to determine the efficacy and
tolerability of a treated gliadincontaining product (GCP) in
asymptomatic subjects with coeliac
disease.
Prof Roy Beran
Strategic Health Evaluators,
Suite 5,
6th Floor,
12 Thomas Street
Chatswood NSW 2067
24-Apr-2007
Archived - Study Complete
Associate Professor Ross Grant
CEO - Australasian Research
Institute
Chief Scientist
Australasian Research Institute
185 Fox Valley Road
Wahroonga NSW 2076
04-Apr-2007
Archived - Study Complete
05/07
An international multi-centre study of
tamoxifen vs anastrozole in
postmenopausal women with hormone
sensitive ductal carcinoma in situ
(DCIS) (IBIS II – DCIS).
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
04-Apr-2007
Recruitment Ceased
04/07
The effect of diet and lifestyle on
serum adipocytokine levels in
adolescent females: implications for
insulin resistance and Type 2
diabetes.
Associate Professor Ross Grant
CEO - Australasian Research
Institute
Chief Scientist
Australasian Research Institute
185 Fox Valley Road
Wahroonga NSW 2076
04-Apr-2007
Archived - Study Complete
03/07
Cognitive performance and closed
loop stimulation. (COGNITION)
04-Apr-2007
Archived - Study Complete
02/07
A 12-month double-blind, randomized,
multicenter, active-controlled, parallelgroup study comparing the efficacy
and safety of 0.5mg and 1.25mg
fingolimod (FTY 720) administered
orally once daily versus interferon B1a (Avonex â)administered i.m. once
weekly in patients with relapsingremitting multiple sclerosis.
(TRANSFORMS)
07-Feb-2007
Archived - Study Complete
06/07
A/Prof Robert Heard
55 Hills Street
Gosford NSW 2250
Archived - Rejected
Updated 1-Sep-2014
01/07
New leaves poetry writing project.
Ms Carolyn Rickett
PO Box 19
Cooranbong NSW 2265
04-Apr-2007
Archived - Study Complete
25/06
A frequent optimization study using the
QuickOpt Method. (FREEDOM)
Dr Peter Illes
502 San Clinic
185 Fox Valley Road
Wahroonga NSW 2076
07-Feb-2007
Archived - Study Complete
24/06
Randomised comparative study of
FOLFOX6m plus SIR-spheres versus
FOLFOX6m alone as first line
treatment in patients with nonresectable liver metastases from
primary colorectal carcinoma.
(SIRFLOX)
Randomised, double-blind, placebocontrolled, parallel-group, doseranging study to investigate the MRI
efficacy and the safety of six months
administration of firategrast (1501200mg twice daily) in subjects with
relapsing-remitting multiple sclerosis.
(TIME)
Responding to the needs and quality
of life experiences of advanced nonsmall cell lung cancer: a focus groups
study of patients and carers.
Comparison of adipocytokine levels in
age, sex and BMI matched vegetarian
versus non-vegetarian adults.
A phase III randomized, double-blind
placebo-controlled, multicentre clinical
trial of Rebif new formulation (44mcg
tiw and 44 mcg ow) in subjects at high
risk of converting to multiple sclerosis
(REFLEX).
Pilot study for pathways to the
diagnosis of thyroid cancer in NSW.
Dr Gavin Marx
San Clinical Trials Unit
Sydney Adventist Hospital
185 Fox Valley Road
Wahroonga NSW 2076
04-Oct-2006
Recruitment Ceased
04-Oct-2006
Archived - Withdrawn
18-Dec-2006
Archived - Study Complete
04-Oct-2006
Archived - Study Complete
04-Oct-2006
Archived - Withdrawn
04-Oct-2006
Archived - Study Complete
16-Nov-2006
Archived - Study Complete
04-Oct-2006
Archived - Study Complete
02-Aug-2006
Archived - Study Complete
02-Aug-2006
Archived - Discontinued
07-Jun-2006
Archived - Study Complete
07-Jun-2006
Archived - Discontinued
07-Jun-2006
Archived - Withdrawn
07-Jun-2006
Archived - Discontinued
16-Apr-2006
Archived - Study Complete
05-Apr-2006
Archived - Study Complete
23/06
22/06
21/06
20/06
19/06
18/06
17/06
16/06
15/06
14/06
13/06
12/06
11/06
10/06
09/06
Audit of complication rates and
outcomes from radiotherapy treatment
of prostate cancer.
The effect of reflexology therapy on
cancer patients (particularly breast
cancer).
Investigation of clinical endpoints for
treatment-induced gastroesophageal
reflux disease (GERD) symptom
changes.
A randomised single-blind study to
improve health-related quality of life as
measured by the SF-36 vitality score
by correcting anaemia of chronic
kidney disease with Aranespâ in the
elderly. (STIMULATE)
Sensory evaluation and taste
threshold data of the minor
components of soybeans in soy foods.
IBCSG 23-01 A randomised trial of
axillary dissection versus no axillary
dissection for patients with clinically
node negative breast cancer and
micrometastases in the sentinel node.
(IBCSG 23-01)
The effect lipid lowering agents on fat
metabolism during aerobic exercise in
dyslipidemic individuals
A multi-centre randomized trial of
sentinel node versus axillary clearance
in operable breast cancer.(SNAC2)
A long term non-interventional study to
evaluate the effectiveness of Aranesp
in dialysis patients when administered
once every two weeks. (ALTERNATE)
Evaluation of variance in the
immunogenic activity of hydrolysed
selected wheat proteins using isolated
human T-cells from celiac sufferers
Updated 1-Sep-2014
08/06
07/06
06/06
05/06
04/06
03/06
A retrospective audit of patients
undergoing percutaneous closure of
patent foramen ovale
A randomized, double-blind, placebocontrolled, proof of concept study of
Zoledronic acid in spontaneous
osteonecrosis of the knee (SONK).
(The Zo-SONK study).
Progesterone after previous preterm
birth for the prevention of neonatal
respiratory distress syndrome.
(PROGRESS)
Prospective comparison of the
immunological response following
robotic assisted and open retropubic
radical prostatectomy for organ
confined prostate carcinoma.
A study of sharps injuries among SAH
staff following adoption of the
Sharpsmart Safety Device.
A prospective, multicentre clinical trial
to evaluate functional outcomes and
wear in alumina-Delta bearing
surfaces, after primary uncemented
total hip replacements.
02/06
Pacing alternate sites using
SelectSecure. (PASSES)
01/06
Ethics Committee endorsement as an
Authorised Prescriber of an
unapproved product under section
19(5) of the Therapeutic Goods Act.
Dr William K Walter
Specialist Orthopaedic Group,
Mater Clinic,
Suite 1.08,
Level 1,
3-9 Gilles Street
North Sydney NSW 2060
Dr David McHarg
Practice Manager
Practice Manager
Northern Nuclear Medicine
Suite 306 The San Clinic
07-Jun-2006
Archived - Study Complete
07-Jun-2006
Archived - Discontinued
07-Jun-2006
Archived - Discontinued
05-Apr-2006
Archived - Discontinued
05-Apr-2006
Archived - Study Complete
05-Apr-2006
Archived - Study Complete
05-Apr-2006
Archived - Study Complete
01-Feb-2006
Archived - Study Complete
17-Aug-2005
Archived - Study Complete
06-Apr-2005
Archived - Discontinued
185 Fox Valley Rd
Wahroonga NSW 2076
09/05
Vitamin B12 supplementing efficacy of
Propionibacterium jensenii 702
08/05
CT0501: Non-comparative, multicentre study to evaluate the safety and
efficacy of DePuy Silent Hip prosthesis
in primary total hip replacement.
07/05
TVT-O prospective outcomes study
06-Apr-2005
Archived - Study Complete
05/05
Access to Medical Records
02-Feb-2005
Archived - Study Complete
04/05
Sydney – Newcastle Adventist
Schools: Teen physical activity and
nutrition study
Exploring post operative delirium
(POD) in the elective, major, colorectal
surgical population
Anxiety in patients who undergo
successful percutaneous coronary
intervention (PCI) over time
Poster presentation of CT and X-ray
case of paediatric osteomyelitis
02-Feb-2005
Archived - Study Complete
02-Feb-2005
Archived - Study Complete
02-Feb-2005
Archived - Study Complete
02-Feb-2005
Archived - Study Complete
Association of the Use of Adrenaline in
Cardiac Arrest and Outcome,
Particularly Stroke – A Case Study
National Midwifery Competencies
Project
10-Nov-2004
Archived - Study Complete
10-Nov-2004
Archived - Study Complete
17/04
Colonoscopy Research in Symptom
Prediction (CRISP)
01-Sep-2004
Archived - Study Complete
16/04
BotuliniumToxin Type A for Urinary
Urgency
01-Sep-2004
Archived - Study Complete
15/04
Prospective Safety and efficacy study
of the PTQ Implantation Procedure for
the treatment of patients diagnosed
01-Sep-2004
Archived - Study Complete
03/05
02/05
01/05
20/04
18/04
Dr James Sullivan
SportsMed West,
116 Macquarie Street
Parramatta NSW 2150
Updated 1-Sep-2014
with Passive Faecal Incontinence
14/04
A Sentinel Study of Cardiovascular
Disease Risk Factors in Australia
01-Sep-2004
Archived - Study Complete
13/04
Developing and Understanding of
Family and Social influences on
Children’s Physical Activity and
Participation in a Community Sporting
Event
Cancer Caregiver Needs Study. Pilot
Study
01-Sep-2004
Archived - Study Complete
01-Sep-2004
Archived - Study Complete
11/04
Authorised Prescriber
01-Sep-2004
Archived - Study Complete
10/04
Stress and Burnout within nursing and
midwifery professions
05-May-2004
Archived - Study Complete
09/04
Gluten-Free Wheat Trial. A pilot study.
05-May-2004
Archived - Study Complete
08/04
The Determination of Glycaemic Index
of Foods
31-May-2004
Archived - Study Complete
07/04
Equol Production Ability of vegetarians
and non-vegetarians to convert
daidzein to equol
Topical treatments for radiation
induced skin responses: a repeated
measures, comparative study of a tea
tree oil and a paw paw cream dressing
Age induced changes in the Human
Urinary Bladder
31-May-2004
Archived - Study Complete
05-May-2004
Archived - Study Complete
18-Feb-2004
Archived - Study Complete
Retrospective Review of Patients who
underwent surgery for Prolapse at
SAH
Prospective Safety and Efficacy study
of Midline Intravaginal Slingplasty for
treatment of Urinary Stress
Incontinence
Neurochemicals and their Receptors in
Human Urinary Bladder
18-Feb-2004
Archived - Study Complete
18-Feb-2004
Archived - Discontinued
18-Feb-2004
Archived - Study Complete
18-Feb-2004
Archived - Study Complete
12/04
06/04
05/04
04/04
03/04
02/04
Dr David Harris
PO Box 40
COORANBONG NSW 2265
01/04
Trial to Reduce the Incidence of Type
1 diabetes in the Genetically at Risk
(TRIGR study)
13/03
Detection of Human Chlamydia
pneumoniae infection
12-Nov-2003
Archived - Study Complete
12/03
Stroke patients’ abilities to stand up
and to walk after discharge from
rehabilitation
Study of Heart and Renal Protection
(SHARP): a randomised placebo
controlled study to assess the effects
of cholesterol-lowering therapy with a
combination of simvastatin and
ezetimibe on the risk of major
cardiovascular complications among
individuals with renal impairment
Mental Fatigue after Walking Exercise
12-Nov-2003
Archived - Study Complete
12-Nov-2003
Archived - Study Complete
03-Sep-2003
Archived - Study Complete
Safety and preliminary efficacy study
for the MiniaturoTMI system utilized
for the treatment of patients diagnosed
with interstitial cystitis (IC), overactive
bladder (OAB) & urinary urge
incontinence (UUI)
Volitional Strategies of Self-Regulation
03-Sep-2003
Archived - Study Complete
03-Sep-2003
Archived - Study Complete
Observational Study of Common
remedies of nausea and vomiting
during pregnancy
02-Mar-2003
Archived - Study Complete
11/03
10/03
09/03
08/03
07/03
Dr Neville J Howard
Institute of Endocrinology &
Diabetes,
The Children’s Hospital at
Westmead,
Locked Bag 4001
Westmead NSW 2145
Updated 1-Sep-2014
06/03
Control of proliferative lifespan in
Human Breast Epithelial Cells
05/03
Prayer Power Project
04/03
Characterisation of naturally occurring
variations in the cellular genes of
children
Isolation and Cryopreservation of Cord
Blood Stem Cells. Setting up a Stem
Cell Unit
AuSPEN Nutritional Support Study
19-Mar-2002
Archived - Study Complete
19-Mar-2002
Archived - Study Complete
19-Mar-2002
Archived - Study Complete
01/03
Transition Support Programs for New
Graduate Nurses
19-Mar-2002
Archived - Study Complete
15/02
A Sentinel Study of Trends in
Coronary Heart Disease Risk Factors
in Australia. ARC Linkage Project
Transition Support Programs for new
Grad Nurses – How effective are they?
11-Nov-2002
Archived - Study Complete
11-Nov-2002
Archived - Study Complete
Characterisation of picolinic acid levels
and related metabolites in human
cerebrospinal fluid and serum
Multicentre phase 3 open label study
to assess patient preference and
sexual encounter attributes of men
with switching from sildenafil citrate to
tadalafil 20mg.
A Phenomenological Study of what is
uniquely SDA in Operation of SAH
06-Nov-2002
Archived - Study Complete
06-Nov-2002
Archived - Study Complete
01-Sep-2002
Archived - Study Complete
03-Jul-2002
Archived - Study Complete
03/03
02/03
14/02
13/02
11/02
10/02
07-Jul-2003
Archived - Study Complete
Archived - Study Complete
09/02
A pilot study to assess the clinical
importance of the Silent Hip
08/02
Does Splinting prevent contracture
following stroke
03-Jul-2002
Archived - Study Complete
07/02
The lived experience of coping with
renal disease and dialysis treatment
01-May-2002
Archived - Study Complete
06/02
The re-invasion of the medicalised
birth: An investigation into the desire
for medical intervention during
pregnancy and childbirth
Approval for use of interventional
devices
01-May-2002
Archived - Study Complete
01-May-2002
Archived - Study Complete
The incidence and characteristics of
pain (stump pain and phantom pain)
and phantom sensations in amputees
attending prosthetic clinics in Sydney
A clinical trial of the efficacy of the
topical skin cream 101CSD to resolve
superficial basal cell carcinoma
A prospective, multicentre, populationbased laboratory surveillance for
candidaemia in Australia over a three
year period
ERCP Audit at Sydney Adventist
Hospital
06-Mar-2002
Archived - Study Complete
06-Mar-2002
Archived - Study Complete
06-Mar-2002
Archived - Study Complete
06-Mar-2002
Archived - Study Complete
12/01
Survey of Occupational Health and
Safety Services in Hospitals
21-Mar-2001
Archived - Study Complete
11/01
Concerns of caregivers of persons
with cancer
21-Mar-2001
Archived - Study Complete
10/01
Australian Breast Cancer Family Study
21-Mar-2001
Archived - Study Complete
09/01
Temperament variables of personality
as modifiers of symptoms in stress
burnout and burnt out individuals
The origins of antibiotic resistance
genes in multi-drug resistant clinical
isolates
Stress and postnatal depression
21-Mar-2001
Archived - Study Complete
21-Mar-2001
Archived - Study Complete
21-Mar-2001
Archived - Study Complete
05/02
04/02
03/02
02/02
01/02
08/01
07/01
Dr James Sullivan
SportsMed West,
116 Macquarie Street
Parramatta NSW 2150
Updated 1-Sep-2014
06/01
Initiating Dialysis Early and Late
(IDEAL)
21-Mar-2001
Archived - Withdrawn
05/01
The use of electromyographic
biofeedback as an adjunct to
occupational therapy in improving
motor control of the upper limb after
cerebrovascular accident
Not for Resuscitation (NFR) Policy
21-Mar-2001
Archived - Study Complete
21-Mar-2001
Archived - Study Complete
Assessment of human prostate
pathology by in-vivo magnetic
resonance imaging and spectroscopy
Socio-economic factors and patterns
of care in lung cancer
21-Mar-2001
Archived - Study Complete
21-Mar-2001
Archived - Study Complete
The experience of newly registered
nurses when faced with ethical
situations that challenge their personal
values and belief systems
21-Mar-2001
Archived - Study Complete
04/01
03/01
02/01
01/01